News & Perspective

Feb 11, 2005

Feb 11, 2005

Proposed budget cuts state biodefense funds, boosts drug stockpile

(CIDRAP News) – The Bush administration has proposed cutting funds that support state and local preparedness for bioterrorism and other health emergencies in fiscal year 2006, drawing protests from public health advocacy groups.

However, the proposal for the fiscal year that begins next October would increase funding for the nation's emergency stockpile of drugs and medical supplies by more than 50%. The budget was released Feb 7.

Sep 15, 2005

Sep 15, 2005

US boosts medical stockpile for flu pandemic

(CIDRAP News) – The federal government is spending about $103 million to boost its small supplies of avian influenza vaccine and antiviral drugs to battle a possible flu pandemic, health officials announced today.

Aug 08, 2006

Aug 08, 2006

Professional groups call on White House to elevate role of pandemic flu vaccines

(CIDRAP News) – Two national groups of infectious disease experts urged the White House to make the development of vaccines the most important element in the nation's pandemic influenza plan.

Jan 25, 2007

Jan 25, 2007

IDSA urges requiring flu shots for healthcare workers

(CIDRAP News) – Influenza shots should be mandatory for healthcare workers, and public health officials should think of seasonal flu as a dress rehearsal for pandemic flu, the Infectious Diseases Society of America (IDSA) said today as it unveiled a 12-point plan to strengthen the nation's preparedness.

Feb 23, 2007

Feb 23, 2007

APHA offers plan for boosting pandemic preparedness

(CIDRAP News) – The nation's largest public health group, the American Public Health Association (APHA), yesterday released recommendations aimed at strengthening existing federal strategies for pandemic preparedness and encouraging local officials and businesses to play key roles.

Oct 16, 2007

Oct 16, 2007

US funds work on drugs for plague, tularemia, anthrax

(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Bibliography

Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Oct 26, 2009

Oct 26, 2009

Emergency authorization for peramivir draws fast response

(CIDRAP News) – Requests to use the intravenous (IV) antiviral drug peramivir in hospitalized H1N1 flu patients came quickly after the government issued an emergency use authorization (EUA) Oct 23, a Centers for Disease Control and Prevention (CDC) official said today.

Oct 29, 2009

Oct 29, 2009

Statins may help patients with severe seasonal flu

(CIDRAP News) – Commonly available drugs that are sold in lower-cost generic versions improve the survival of patients hospitalized for seasonal influenza, researchers reported today, raising the possibility of a widely available treatment that could be used in a severe flu pandemic if other drugs are in short supply.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»